• レポートコード:PMR2008013 • 出版社/出版日:Persistence Market Research / 2020年7月31日 • レポート形態:英文、PDF、300ページ • 納品方法:Eメール • 産業分類:消費財 |
Individual User(1名用) | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User(5名用) | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User(企業用) | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、OTCコンシューマーヘルスケアの世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場におけるリスク・機会、新型コロナウイルスの市場への影響、新型コロナウイルスのOTCコンシューマーヘルスケア市場への影響、新型コロナウイルスの小売業への影響、需要分析・予測、価格分析、市場背景、製品別(OTC医薬品、ダイエットサプリメント)分析、エンドユーザー別(12-19歳、男性、女性、キッズ)分析、フォームタイプ別(タブレット、粉末、液体、その他)分析、販売経路別(卸売業者・販売業者、薬局/ドラッグストア、専門店、オンライン小売業者、ハイパーマーケット/スーパーマーケット)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場におけるリスク・機会 ・新型コロナウイルスの市場への影響 ・新型コロナウイルスのOTCコンシューマーヘルスケア市場への影響 ・新型コロナウイルスの小売業への影響 ・需要分析・予測 ・価格分析 ・市場背景 ・OTCコンシューマーヘルスケアの世界市場規模:製品別(OTC医薬品、ダイエットサプリメント) ・OTCコンシューマーヘルスケアの世界市場規模:エンドユーザー別(12-19歳、男性、女性、キッズ) ・OTCコンシューマーヘルスケアの世界市場規模:フォームタイプ別(タブレット、粉末、液体、その他) ・OTCコンシューマーヘルスケアの世界市場規模:販売経路別(卸売業者・販売業者、薬局/ドラッグストア、専門店、オンライン小売業者、ハイパーマーケット/スーパーマーケット) ・OTCコンシューマーヘルスケアの世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Persistence Market Research (PMR) has recently published a new research analysis on the OTC consumer healthcare market for the assessment period of 2020-2030. The research study offers a close look at the evolving aspects of the OTC consumer healthcare market and the dynamics impacting market growth. It also focuses on key developments that have made a mark in the OTC consumer healthcare market, and what other developments are on the cards. The report talks about various macro- and micro-economic factors responsible for giving an in-depth analysis of the market.
The research study on the OTC consumer healthcare market extensively focuses on key trends shaping its growth. In addition, opportunity analysis on OTC consumer healthcare underline untapped corners for aspiring players to make a note of. In addition, this research study on the OTC consumer healthcare market also offers a panoramic view of the incremental opportunity, which can further help readers make well-informed decisions.
Several stakeholders in the OTC consumer healthcare market can rely on the data offered in this research study and delve into pragmatic decision-making. Moreover, information offered in the report also can help new market entrants expand their bases in the OTC consumer healthcare market.
The report elaborates on both, historical and current trends molding the growth of the OTC consumer healthcare market. The performance of the OTC consumer healthcare market has been drawn and analyzed in ways that the lucrative side of the market is evident to readers. Competitive landscape provided in the report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Key Statistics
1.3. Summary of Key Findings
1.4. Product Evolution Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.1.1. The Entrance of New Brands Aggravates Competition
3.1.2. People have now switched to self-treatment
3.1.3. Analgesics to Continue Dominating the Market in the Coming Years
3.1.4. Growing Preferences for Natural Medicinal Products and Supplements
3.1.5. Changing Retail landscape
3.1.6. Globalization Impacting Lifestyles
3.1.7. Others
3.2. Product Innovation Trends
3.3. Evolution of OTC Healthcare Industry
3.4. Winning Themes
3.4.1. New Product Innovations- Clinical Evidence Supporting Their Claims
3.4.2. Effective Marketing- Key Active Ingredients
4. Risk and Opportunities in The Market
4.1. Associated Risk
4.1.1. Regulatory Landscape Associated Risk
4.1.2. Standard & Certification Risk
4.2. Opportunities
4.2.1. Niche Within The Existing Product Line
4.2.2. Opportunities In New Product Categories
4.2.3. Latent Opportunities In Established Market
4.3. Key Regulations & Industrial Standards
4.3.1. Rules & Regulations By Countries
4.3.2. Regulations With Respect To Imports
5. Impact of Covid-19 on The Market
5.1. Covid-19 The Situation Now
5.2. The Effects of National Lockdown in Various Countries
5.3. Scenarios For The Economic Impact of The Covid-19 Crisis
5.4. Industries Affected By Coronavirus Outbreak Worldwide
5.5. Projected Recovery for Hardest Hit Sectors
5.6. Coronavirus Impact on The World of Work
5.7. Impact of Covid-19 on Manufacturing Industry
5.8. Manufacturing Purchasing Managers Index, 2020
5.9. Impact of Covid-19 on Supply Chain Worldwide
5.10. Planning & Managing During Covid-19 Pandemic
5.11. Upcoming Pointers Business Leaders Should Focus On
6. Impact of Covid-19 on The OTC Consumer Healthcare Market
6.1. Impact of Covid-19 on the Industry
6.2. Covid-19 Impact v/s Value of OTC Consumer Healthcare Market, by Country 2020
6.3. OTC Consumer Healthcare Sales Projection, Q1-Q4 2020 During Covid-19 Pandemic
6.4. Pre Covid-19 Market Forecast v/s Post covid-19 Market Forecast
7. Covid-19 Impact on Retail Industry
7.1. Coronavirus Impact Matrix
7.2. Sales Increased Dramatically Across Most Categories; Paper Products, Home Care, and Personal Care Products Spiked in all Countries
7.3. Global Consumers Impact – Winning and Losing Segment Spending
7.4. Consumer Sentiment Reflects Fear of the Virus and of Recession
8. Global OTC Consumer Healthcare Market Demand Analysis 2015-2019 and Forecast, 2020-2030
8.1. Historical Market Volume (Mn Tons) Analysis, 2015-2019
8.2. Current and Future Market Volume (Mn Tons) Projections, 2020-2030
8.3. Y-o-Y Growth Trend Analysis
9. Global OTC Consumer Healthcare Market – Pricing Analysis
9.1. Regional Pricing Analysis By Product
9.2. Pricing Break-up
9.2.1. Manufacturer Level Pricing
9.2.2. Distributor Level Pricing
9.3. Global Average Pricing Analysis Benchmark
10. Global OTC Consumer Healthcare Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
10.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
10.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
10.2.1. Y-o-Y Growth Trend Analysis
10.2.2. Absolute $ Opportunity Analysis
11. Market Background
11.1. OTC Consumer Healthcare Products Industry
11.1.1. Prescribed vs OTC Healthcare Products Consumption Analysis
11.1.2. Top Global Player In Industry
11.1.3. Per Capita Spending on OTC Products
11.1.4. Penetration of OTC Consumer Healthcare Products in the Global Market
11.2. Macro-Economic Factors
11.2.1. Global GDP Growth Outlook
11.2.2. GDP Growth Rate Analysis
11.2.3. Global Industry Value Added
11.2.4. Global E-Commerce Industry Outlook
11.2.5. Per Capital Spending Outlook
11.2.6. Urbanization Growth Outlook
11.2.7. Global Healthcare Industry Outlook
11.3. Industry Value and Supply Chain Analysis
11.3.1. Profit Margin Analysis at each sales point
11.3.2. List & role of key participants
11.3.2.1. Manufacturers
11.3.2.2. Distributors/Retailers
11.3.2.3. List of Private Label Brands
11.4. Forecast Factors – Relevance & Impact
11.4.1. Top Companies Historical Growth
11.4.2. Global Pharmaceutical Industry Outlook
11.4.3. Global Consumer Price Index Outlook
11.4.4. Manufacturing Sector Gross Value Added
11.4.5. Global Retail Sales Outlook
11.5. Consumer Sentiment Analysis
11.5.1. Which Specific Brand Is Preferred By The Consumers And Why?
11.5.2. Factors Influencing Market Behaviour
11.5.3. Which Mode Of Advertisement Does Vendors Prefer?
11.5.4. What Are The Key Challenges Associated With The Market Suppliers?
11.5.5. Others
11.6. PESTLE Analysis of OTC Consumer Healthcare Market
11.7. Investment Feasibility Matrix of OTC Consumer Healthcare Market
11.8. Porter’s Five Force
11.9. Product Development and Launches
11.10. Market Dynamics
11.10.1. Drivers
11.10.2. Restraints
11.10.3. Opportunity Analysis
12. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Product
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Product, 2015 – 2019
12.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Product, 2020 – 2030
12.3.1. OTC Pharmaceutical
12.3.1.1. Eye Care
12.3.1.2. Oral Health Care
12.3.1.3. Medicated Skin Care
12.3.1.4. Wound Care
12.3.1.5. Digestive Remedies
12.3.1.6. Sleeping Aids
12.3.1.7. Emergency Contraceptives
12.3.1.8. Intimate Care
12.3.1.9. Hair Care
12.3.1.10. Cough Cold & Allergy Remedies
12.3.1.11. Analgesics
12.3.1.12. Dermatological
12.3.2. Dietary Supplements
12.3.2.1. Nutrition
12.3.2.2. Vitamins
12.3.2.3. Minerals
12.3.2.4. Proteins
12.3.2.5. Others
12.4. Market Attractiveness Analysis By Product
13. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by End-user
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By End-user, 2015 – 2019
13.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By End-user, 2020 – 2030
13.3.1. 12-19 Years
13.3.2. Male
13.3.3. Female
13.3.4. Kids
13.4. Market Attractiveness Analysis By End-user
14. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Form Type
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Form Type, 2015 – 2019
14.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Form Type, 2020 – 2030
14.3.1. Tablets
14.3.2. Powders
14.3.3. Liquids
14.3.4. Others
14.4. Market Attractiveness Analysis By Form Type
15. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Sales Channel
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Sales Channel, 2015 – 2019
15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Sales Channel, 2020 – 2030
15.3.1. Wholesalers & Distributors
15.3.2. Pharmacy or Drug Stores
15.3.3. Speciality Stores
15.3.4. Online Retailers
15.3.5. Hypermarkets/Supermarkets
15.3.6. Other Sales Channel
15.4. Market Attractiveness Analysis By Sales Channel
16. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Region
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Region, 2015 – 2019
16.3. Current Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Region, 2020 – 2030
16.3.1. North America
16.3.2. Europe
16.3.3. Middle East and Africa (MEA)
16.3.4. East Asia
16.3.5. South Asia
16.3.6. Oceania
16.3.7. Latin America
16.4. Market Attractiveness Analysis By Region
17. North America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
17.4.1. By Country
17.4.1.1. U.S.
17.4.1.2. Canada
17.4.2. By Product
17.4.3. By End-user
17.4.4. By Form Type
17.4.5. By Sales Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By End-user
17.5.4. By Form Type
17.5.5. By Sales Channel
17.6. Market Trends
17.7. Key Market Participants – Intensity Mapping
17.8. Drivers and Restraints – Impact Analysis
18. Latin America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
18.4.1. By Country
18.4.1.1. Brazil
18.4.1.2. Mexico
18.4.1.3. Rest of Latin America
18.4.2. By Product
18.4.3. By End-user
18.4.4. By Form Type
18.4.5. By Sales Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By End-user
18.5.4. By Form Type
18.5.5. By Sales Channel
18.6. Market Trends
18.7. Key Market Participants – Intensity Mapping
18.8. Drivers and Restraints – Impact Analysis
19. Europe OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
19.4.1. By Country
19.4.1.1. Germany
19.4.1.2. U.K.
19.4.1.3. Spain
19.4.1.4. France
19.4.1.5. Italy
19.4.1.6. Rest Of Europe
19.4.1.7. Rest of Europe
19.4.2. By Product
19.4.3. By End-user
19.4.4. By Form Type
19.4.5. By Sales Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By End-user
19.5.4. By Form Type
19.5.5. By Sales Channel
19.6. Market Trends
19.7. Key Market Participants – Intensity Mapping
19.8. Drivers and Restraints – Impact Analysis
20. South Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
20.4.1. By Country
20.4.1.1. India
20.4.1.2. Thailand
20.4.1.3. Malaysia
20.4.1.4. Indonesia
20.4.1.5. Rest of South Asia
20.4.2. By Product
20.4.3. By End-user
20.4.4. By Form Type
20.4.5. By Sales Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By End-user
20.5.4. By Form Type
20.5.5. By Sales Channel
20.6. Market Trends
20.7. Key Market Participants – Intensity Mapping
20.8. Drivers and Restraints – Impact Analysis
21. East Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.2. Pricing Analysis
21.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
21.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
21.4.1. By Country
21.4.1.1. China
21.4.1.2. Japan
21.4.1.3. South Korea
21.4.2. By Product
21.4.3. By End-user
21.4.4. By Form Type
21.4.5. By Sales Channel
21.5. Market Attractiveness Analysis
21.5.1. By Country
21.5.2. By Product
21.5.3. By End-user
21.5.4. By Form Type
21.5.5. By Sales Channel
21.6. Market Trends
21.7. Key Market Participants – Intensity Mapping
21.8. Drivers and Restraints – Impact Analysis
22. Oceania OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
22.1. Introduction
22.2. Pricing Analysis
22.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
22.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
22.4.1. By Country
22.4.1.1. Australia
22.4.1.2. New Zealand
22.4.2. By Product
22.4.3. By End-user
22.4.4. By Form Type
22.4.5. By Sales Channel
22.5. Market Attractiveness Analysis
22.5.1. By Country
22.5.2. By Product
22.5.3. By End-user
22.5.4. By Form Type
22.5.5. By Sales Channel
22.6. Market Trends
22.7. Key Market Participants – Intensity Mapping
22.8. Drivers and Restraints – Impact Analysis
23. Middle East and Africa OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030
23.1. Introduction
23.2. Pricing Analysis
23.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
23.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030
23.4.1. By Country
23.4.1.1. GCC Countries
23.4.1.2. Northern Africa
23.4.1.3. South Africa
23.4.1.4. Rest of MEA
23.4.2. By Product
23.4.3. By End-user
23.4.4. By Form Type
23.4.5. By Sales Channel
23.5. Market Attractiveness Analysis
23.5.1. By Country
23.5.2. By Product
23.5.3. By End-user
23.5.4. By Form Type
23.5.5. By Sales Channel
23.6. Market Trends
23.7. Key Market Participants – Intensity Mapping
23.8. Drivers and Restraints – Impact Analysis
24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies (OTC Consumer Healthcare)
24.2. Market Concentration
24.3. Market Share Analysis of Top Players
24.4. Market Presence Analysis
24.4.1. By Regional footprint of Players
24.4.2. Product foot print by Players
24.4.3. Channel Foot Print by Players
25. Competition Analysis
25.1. Competition Dashboard
25.2. Pricing Analysis by Competition
25.3. Competition Benchmarking
25.4. Competition Deep Dive
25.4.1. Sun Pharmaceutical Industries Limited
25.4.1.1. Overview
25.4.1.2. Product Portfolio
25.4.1.3. Profitability by Market Segments (Product/Channel/Region)
25.4.1.4. Sales Footprint
25.4.1.5. Strategy Overview
25.4.1.5.1. Marketing Strategy
25.4.1.5.2. Product Strategy
25.4.1.5.3. Channel Strategy
25.4.2. Glenmark Pharmaceuticals Ltd.
25.4.2.1. Overview
25.4.2.2. Product Portfolio
25.4.2.3. Profitability by Market Segments (Product/Channel/Region)
25.4.2.4. Sales Footprint
25.4.2.5. Strategy Overview
25.4.2.5.1. Marketing Strategy
25.4.2.5.2. Product Strategy
25.4.2.5.3. Channel Strategy
25.4.3. Johnson & Johnson Private Ltd, Pfizer, Inc.
25.4.3.1. Overview
25.4.3.2. Product Portfolio
25.4.3.3. Profitability by Market Segments (Product/Channel/Region)
25.4.3.4. Sales Footprint
25.4.3.5. Strategy Overview
25.4.3.5.1. Marketing Strategy
25.4.3.5.2. Product Strategy
25.4.3.5.3. Channel Strategy
25.4.4. American Health Corporation
25.4.4.1. Overview
25.4.4.2. Product Portfolio
25.4.4.3. Profitability by Market Segments (Product/Channel/Region)
25.4.4.4. Sales Footprint
25.4.4.5. Strategy Overview
25.4.4.5.1. Marketing Strategy
25.4.4.5.2. Product Strategy
25.4.4.5.3. Channel Strategy
25.4.5. Abbott Laboratories Inc.
25.4.5.1. Overview
25.4.5.2. Product Portfolio
25.4.5.3. Profitability by Market Segments (Product/Channel/Region)
25.4.5.4. Sales Footprint
25.4.5.5. Strategy Overview
25.4.5.5.1. Marketing Strategy
25.4.5.5.2. Product Strategy
25.4.5.5.3. Channel Strategy
25.4.6. GlaxoSmithKline plc
25.4.6.1. Overview
25.4.6.2. Product Portfolio
25.4.6.3. Profitability by Market Segments (Product/Channel/Region)
25.4.6.4. Sales Footprint
25.4.6.5. Strategy Overview
25.4.6.5.1. Marketing Strategy
25.4.6.5.2. Product Strategy
25.4.6.5.3. Channel Strategy
25.4.7. Sanofi S.A.
25.4.7.1. Overview
25.4.7.2. Product Portfolio
25.4.7.3. Profitability by Market Segments (Product/Channel/Region)
25.4.7.4. Sales Footprint
25.4.7.5. Strategy Overview
25.4.7.5.1. Marketing Strategy
25.4.7.5.2. Product Strategy
25.4.7.5.3. Channel Strategy
25.4.8. Piramal Enterprises Ltd.
25.4.8.1. Overview
25.4.8.2. Product Portfolio
25.4.8.3. Profitability by Market Segments (Product/Channel/Region)
25.4.8.4. Sales Footprint
25.4.8.5. Strategy Overview
25.4.8.5.1. Marketing Strategy
25.4.8.5.2. Product Strategy
25.4.8.5.3. Channel Strategy
25.4.9. Boehringer Ingelheim GmbH
25.4.9.1. Overview
25.4.9.2. Product Portfolio
25.4.9.3. Profitability by Market Segments (Product/Channel/Region)
25.4.9.4. Sales Footprint
25.4.9.5. Strategy Overview
25.4.9.5.1. Marketing Strategy
25.4.9.5.2. Product Strategy
25.4.9.5.3. Channel Strategy
25.4.10. Bayer AG
25.4.10.1. Overview
25.4.10.2. Product Portfolio
25.4.10.3. Profitability by Market Segments (Product/Channel/Region)
25.4.10.4. Sales Footprint
25.4.10.5. Strategy Overview
25.4.10.5.1. Marketing Strategy
25.4.10.5.2. Product Strategy
25.4.10.5.3. Channel Strategy
25.4.11. Teva Pharmaceutical Industries Ltd.
25.4.11.1. Overview
25.4.11.2. Product Portfolio
25.4.11.3. Profitability by Market Segments (Product/Channel/Region)
25.4.11.4. Sales Footprint
25.4.11.5. Strategy Overview
25.4.11.5.1. Marketing Strategy
25.4.11.5.2. Product Strategy
25.4.11.5.3. Channel Strategy
25.4.12. Ipsen SA, BASF SE
25.4.12.1. Overview
25.4.12.2. Product Portfolio
25.4.12.3. Profitability by Market Segments (Product/Channel/Region)
25.4.12.4. Sales Footprint
25.4.12.5. Strategy Overview
25.4.12.5.1. Marketing Strategy
25.4.12.5.2. Product Strategy
25.4.12.5.3. Channel Strategy
25.4.13. Koninklijke DSM N.V.
25.4.13.1. Overview
25.4.13.2. Product Portfolio
25.4.13.3. Profitability by Market Segments (Product/Channel/Region)
25.4.13.4. Sales Footprint
25.4.13.5. Strategy Overview
25.4.13.5.1. Marketing Strategy
25.4.13.5.2. Product Strategy
25.4.13.5.3. Channel Strategy
25.4.14. Reckitt Benckiser LLC.
25.4.14.1. Overview
25.4.14.2. Product Portfolio
25.4.14.3. Profitability by Market Segments (Product/Channel/Region)
25.4.14.4. Sales Footprint
25.4.14.5. Strategy Overview
25.4.14.5.1. Marketing Strategy
25.4.14.5.2. Product Strategy
25.4.14.5.3. Channel Strategy
25.4.15. Lonza Group Ltd.
25.4.15.1. Overview
25.4.15.2. Product Portfolio
25.4.15.3. Profitability by Market Segments (Product/Channel/Region)
25.4.15.4. Sales Footprint
25.4.15.5. Strategy Overview
25.4.15.5.1. Marketing Strategy
25.4.15.5.2. Product Strategy
25.4.15.5.3. Channel Strategy
25.4.16. Other Players (as per request)
25.4.16.1. Overview
25.4.16.2. Product Portfolio
25.4.16.3. Profitability by Market Segments (Product/Channel/Region)
25.4.16.4. Sales Footprint
25.4.16.5. Strategy Overview
25.4.16.5.1. Marketing Strategy
25.4.16.5.2. Product Strategy
25.4.16.5.3. Channel Strategy
26. Assumptions and Acronyms Used
27. Research Methodology
List Of TablesTable 1: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 2: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 3: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 4: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 5: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 6: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 7: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 8: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 9: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Region, 2015–2030
Table 10: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Region, 2015–2030
Table 11: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 12: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 13: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 14: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 15: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 16: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 17: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 18: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 19: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 20: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 21: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 22: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 23: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 24: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 25: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 26: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 27: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 28: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 29: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 30: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 31: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 32: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 33: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 34: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 35: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 36: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 37: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 38: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 39: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 40: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 41: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 42: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 43: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 44: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 45: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 46: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 47: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 48: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 49: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 50: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 51: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 52: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 53: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 54: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 55: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 56: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 57: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 58: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 59: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 60: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 61: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 62: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 63: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 64: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 65: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 66: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 67: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 68: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 69: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 70: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030
Table 71: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030
Table 72: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030
Table 73: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030
Table 74: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030
Table 75: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030
Table 76: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030
Table 77: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030
Table 78: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030
Table 79: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030
Table 80: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030